Manipulation of Type I Interferon by HIV Infection

Information

  • Research Project
  • 9623549
  • ApplicationId
    9623549
  • Core Project Number
    R15AI138847
  • Full Project Number
    1R15AI138847-01A1
  • Serial Number
    138847
  • FOA Number
    PA-16-200
  • Sub Project Id
  • Project Start Date
    5/15/2018 - 6 years ago
  • Project End Date
    4/30/2021 - 3 years ago
  • Program Officer Name
    LAWRENCE, DIANE M
  • Budget Start Date
    5/15/2018 - 6 years ago
  • Budget End Date
    4/30/2021 - 3 years ago
  • Fiscal Year
    2018
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    5/15/2018 - 6 years ago

Manipulation of Type I Interferon by HIV Infection

Project Summary/Abstract Replication and pathogenesis of any virus within a human host is dependent on how well the virus is able to bypass the many defense systems of the immune system. In particular, Type I Interferons are cytokines that induce the quintessential anti-viral systems within a human. All known viruses that cause disease in humans have systems to circumvent detection and/or action of this potent cytokine. We have sought to determine if and how HIV is able to ?hide? from these systems. We have found that HIV can block both the induction of Type I Interferon as well as the induction of an antiviral state caused by Type I Interferon. We propose to determine how these proteins work to subvert the innate immune response by manipulating the Type I Interferon systems. The significance of these studies will be in creating a more complete understanding of the interaction between HIV and the innate immune system and better understand how to use Type I Interferon in a therapeutic approach to controlling HIV infection. This R15 proposal is a key step in strengthening research opportunities for our laboratory and students that are interested in training in biomedical science research.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R15
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    300000
  • Indirect Cost Amount
    123000
  • Total Cost
    423000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF PHARMACY
  • Funding ICs
    NIAID:423000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    AIP
  • Study Section Name
    AIDS Immunology and Pathogenesis Study Section
  • Organization Name
    WESTERN UNIVERSITY OF HEALTH SCIENCES
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    093373694
  • Organization City
    POMONA
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    917661854
  • Organization District
    UNITED STATES